Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...
Lilly’s senior VP of information and R&D IT Ramesh Durvasula said Lilly will use AI and tech to transform the company.
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly ( LLY -1.74%) is taking a shot at developing one. With the appointment of a new ...
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due ...
Eli Lilly is expanding its innovation digs to Beijing, opening two research centers called the Eli Lilly China Medical ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...
The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...
Best Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback